# DEFERASIROX
> **ANDA209878** · Abbreviated New Drug Application (Generic) · Sponsor: MSN · Approved 2019-11-20
## Drug
- **FDA Application Number:** ANDA209878
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** DEFERASIROX
- **Generic name:** DEFERASIROX
- **Active ingredients:** DEFERASIROX
- **Dosage form:** TABLET, FOR SUSPENSION
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** MSN
- **Manufacturer:** Dr. Reddy's Laboratories Inc
- **First approval:** 2019-11-20
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209878)
---
*AI Analytics · CC0 1.0*